Radiation treatment of carcinoma of the cervix with extension into the endometrium. A reappraisal of its significance
β Scribed by Thongbliew Prempree; Vinita Patanaphan; Thavinsakdi Viravathana; Wilfred Sewchand; Young K. Cho; Ralph M. Scott
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 579 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The clinical efficacy of LC9018, a biological response modifier prepared from heat-killed Lactobacillus casei YIT9018, used in combination with radiation was studied in a randomized controlled trial on 61 patients with carcinoma of the uterine cervix of Stage IIB or 111. The combination therapy with
## Abstract ## BACKGROUND Optimal timing of the measurement of serum squamous cell carcinoma (SCC) antigen during radiation therapy (RT) and its significance for predicting the response of cervical carcinoma patients as early as possible remain unknown. ## METHODS Sixtyβthree patients with SCC o
## BACKGROUND. This study was performed to identify pathologic and clinical features that best predict disease free survival of patients with early stage small cell carcinoma of the cervix treated by radical hysterectomy.
Twelve patients with primary or locally recurrent squamous carcinoma of the cervix were treated with constant internal iliac artery infusion of cisplatin (CDDP) via a totally implantable chemotherapy pump. Seven previously untreated patients received standard external and interstitial radiotherapy (